US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 38.570
  • +0.110+0.29%
Close Apr 26 16:00 ET
  • 37.130
  • -1.440-3.73%
Post 19:49 ET
4.90BMarket Cap18.37P/E (TTM)

Halozyme Therapeutics Key Stats

Halozyme Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 7, 2024

Revenue(YoY)

200.80M

+23.84%
EPS(YoY)

0.59

+102.31%

Strong Buy

Apr 25, 2024

Halozyme Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 208.001M--
May 7, 20242024/Q1-- / 200.799M--
Feb 20, 20242023/Q4230.039M / 231.143M--
Nov 6, 20232023/Q3216.033M / 216.109M--
Aug 8, 20232023/Q2221.038M / 199.951M--
May 9, 20232023/Q1162.143M / 175.517M--
Feb 21, 20232022/Q4181.496M / 192.055M--
Nov 8, 20222022/Q3208.976M / 191.171M--
Aug 9, 20222022/Q2152.365M / 156.000M--
May 10, 20222022/Q1117.279M / 128.504M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 208.001M--
May 7, 20242024/Q1-- / 200.799M--
Feb 20, 20242023/Q4230.039M / 231.143M--
Nov 6, 20232023/Q3216.033M / 216.109M--
Aug 8, 20232023/Q2221.038M / 199.951M--
May 9, 20232023/Q1162.143M / 175.517M--
Feb 21, 20232022/Q4181.496M / 192.055M--
Nov 8, 20222022/Q3208.976M / 191.171M--
Aug 9, 20222022/Q2152.365M / 156.000M--
May 10, 20222022/Q1117.279M / 128.504M--

Unlock Free Earnings Estimates

Halozyme Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 25, 2024

Strong Buy

  • Buy

    77.78%
  • Hold

    22.22%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg